Pfizer Inc. is the only company to withhold a country-by-country breakdown of its tax planning in the Senate Finance Committee’s probe into how Republicans’ 2017 tax package reduced the pharmaceutical industry’s U.S. liabilities, according to a letter Chairman Ron Wyden released Thursday.
Pfizer Lone Holdout In Senate Pharma Tax Probe, Wyden Says
by usoftax_admin | Oct 10, 2024 | Tax News